Published in J Am Soc Nephrol on March 01, 2001
Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells. Br J Pharmacol (2011) 1.01
Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant (2013) 0.97
New-onset diabetes after renal transplantation: risk assessment and management. Diabetes Care (2012) 0.93
Transgenic overexpression of active calcineurin in beta-cells results in decreased beta-cell mass and hyperglycemia. PLoS One (2010) 0.89
Abnormal glucose metabolism and metabolic syndrome in non-diabetic kidney transplant recipients early after transplantation. Transplantation (2010) 0.89
Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers. Br J Clin Pharmacol (2012) 0.85
Metabolic Syndrome Components After Pediatric Liver Transplantation: Prevalence and the Impact of Obesity and Immunosuppression. Am J Transplant (2016) 0.80
Effects of hepatitis C-induced liver fibrosis on survival in kidney transplant candidates. Dig Dis Sci (2007) 0.80
New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT. Int Urol Nephrol (2010) 0.80
Influencing factors of new-onset diabetes after a renal transplant and their effects on complications and survival rate. PLoS One (2014) 0.78
Chronic hepatitis C virus infection and post-liver transplantation diabetes mellitus. World J Gastroenterol (2005) 0.77
New-onset diabetes after kidney transplant in children. Pediatr Nephrol (2014) 0.76
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes. Endocr Rev (2015) 0.76
Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for management. World J Diabetes (2015) 0.76
Pharmacogenetics of posttransplant diabetes mellitus. Pharmacogenomics J (2017) 0.75
Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk Factors. J Pediatr (2016) 0.75
The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord (2000) 3.83
Ramipril and the development of diabetes. JAMA (2001) 3.38
Increased frequency of CMV infection in HLA-DR7 matched renal allograft recipients. Lancet (1993) 1.56
Posttransplantation weight gain is predominantly due to an increase in body fat mass. Transplantation (2000) 1.44
Dietary fibre in the management of diabetes mellitus: a review. Neth J Med (1991) 1.38
Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol (1993) 1.31
Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification. J Clin Microbiol (1998) 1.26
Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J Clin Invest (1993) 1.19
Adoption of disease management model for diabetes in region of Maastricht. BMJ (2001) 1.16
IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients. J Med Virol (1996) 1.09
-to: Waldhäusl W (2001) Editorial: Finally we have arrived in a new millennium. Diabetologia 44: 1-2. Diabetologia (2001) 1.06
From shared care to disease management: key-influencing factors. Int J Integr Care (2001) 1.05
Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab (2000) 1.05
Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects. J Clin Endocrinol Metab (2001) 1.02
Body composition in renal transplant patients: bioimpedance analysis compared to isotope dilution, dual energy X-ray absorptiometry, and anthropometry. J Am Soc Nephrol (1999) 0.98
Miglitol, a new alpha-glucosidase inhibitor. Expert Opin Pharmacother (1999) 0.97
Early detection of human cytomegalovirus infection after kidney transplantation by nucleic acid sequence-based amplification. Transplantation (1999) 0.95
Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes (1999) 0.93
Domestic pigs in the study of myocardial ischemia. Eur Heart J (1983) 0.90
Lipid peroxidation and atherosclerosis in type II diabetes. J Lab Clin Med (1999) 0.90
Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat. Mol Cell Biochem (1999) 0.89
Pitfall of the accessory spleen. Neth J Med (2000) 0.88
Relation between steroid dose, body composition and physical activity in renal transplant patients. Transplantation (2000) 0.88
Significance of haemodynamic variables in coronary care unit for prediction of survival after acute myocardial infarction. Br Heart J (1983) 0.88
A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. Am J Kidney Dis (2001) 0.87
Mechanical properties of mesenteric arteries in diabetic rats: consequences of outward remodeling. Am J Physiol (1999) 0.87
Substitution model with central role for nurse specialist is justified in the care for stable type 2 diabetic outpatients. J Adv Nurs (2001) 0.87
Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment. Diabetes (1998) 0.87
Determinants of injecting insulin in elderly patients with type II diabetes mellitus. Patient Educ Couns (1993) 0.86
Design of a consumer health record for supporting the patient-centered management of chronic diseases. Stud Health Technol Inform (2001) 0.86
Influence of possible HL-A haploidentity on renal-graft survival in Eurotransplant. Lancet (1974) 0.85
Tuberculosis of the thyroid gland. Neth J Med (1988) 0.85
Does the risk of childhood diabetes mellitus require revision of the guideline values for nitrate in drinking water? Environ Health Perspect (2000) 0.83
Recipient hemodynamics during non-heart-beating donor kidney transplantation are major predictors of primary nonfunction. Am J Transplant (2007) 0.82
Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes. Eur J Clin Invest (1993) 0.82
MR renography by semiautomated image analysis: performance in renal transplant recipients. J Magn Reson Imaging (2001) 0.81
Nifedipine and myocardial performance in the presence and absence of beta-blockade with propranolol. Arch Int Pharmacodyn Ther (1983) 0.81
Use of tacrolimus in renal transplantation. Transplant Proc (1999) 0.81
Nifedipine with and without propranolol in the treatment of myocardial ischemia: effect on ventricular arrhythmias and recovery of regional wall function. Eur Heart J (1983) 0.81
Flucloxacillin-associated liver damage. Neth J Med (1982) 0.80
Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients. Transpl Int (2001) 0.80
Immediate and two year prognosis after acute myocardial infarction: prediction from non-invasive as well as invasive parameters in the same individuals. Eur Heart J (1981) 0.80
Acute primary infection with cytomegalovirus (CMV) in kidney transplant recipients results in the appearance of a phenotypically aberrant CD8+ T cell population. Microbiol Immunol (2000) 0.80
MR renography: an algorithm for calculation and correction of cortical volume averaging in medullary renographs. J Magn Reson Imaging (2000) 0.79
Dosing and management guidelines for tacrolimus in renal transplant patients. Transplant Proc (1999) 0.79
Hyperparathyroidism and avascular necrosis of bone after kidney transplantation. A retrospective study of 170 transplant recipients. Neth J Med (1982) 0.78
Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats. Diabetologia (1994) 0.78
Clinical experience with Sandostatin LAR in patients with acromegaly. Neth J Med (2001) 0.78
Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment after kidney transplantation. J Hepatol (1985) 0.78
Nitrate in drinking water and risk of childhood diabetes in The Netherlands. Diabetes Care (1999) 0.78
Early detection of cytomegalovirus in renal transplant recipients: comparison of PCR, NASBA, pp65 antigenemia, and viral culture. Transplant Proc (2000) 0.78
Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus. Thromb Haemost (1997) 0.78
Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy. Transpl Int (1994) 0.78
Pyopneumothorax: a rare complication of Wegener's granulomatosis. Eur J Respir Dis (1985) 0.78
The effect of felodipine on ventricular fibrillation after coronary artery ligation in the anaesthetized pig. Br J Pharmacol (1983) 0.77
Obesity, restrained eating and the cumulative intake curve. Appetite (1988) 0.77
Tissue factor pathway inhibitor activity in patients with IDDM. Diabetes (1995) 0.77
Nucleic acid sequence-based amplification: a new technique for monitoring cytomegalovirus infection in transplant recipients. Transplant Proc (1999) 0.77
Evaluation of a new method for early detection of active cytomegalovirus infections. A study in kidney transplant recipients. Transpl Int (1998) 0.77
[Acute kidney insufficiency in patients treated with fumaric acid esters for psoriasis]. Ned Tijdschr Geneeskd (1989) 0.77
[Acute kidney insufficiency in the treatment of psoriasis using fumaric esters]. Schweiz Med Wochenschr (1989) 0.76
Cardiovascular actions of the calmodulin inhibitor felodipine. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.76
Kidney transplantation using elderly non-heart-beating donors: a single-center experience. Am J Transplant (2006) 0.76
Peripheral blood flow and noradrenaline responsiveness: the effect of physiological hyperinsulinemia. Cardiovasc Res (1997) 0.76
Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes. Diabetes Care (1999) 0.76
Tacrolimus and glucose metabolism. Transplant Proc (1999) 0.76
Substrate utilization and thermogenic responses to beta-adrenergic stimulation in obese subjects with NIDDM. Int J Obes Relat Metab Disord (1999) 0.76
Effects of acarbose (Glucobay) in persons with type 1 diabetes: a multicentre study. Diabetes Res Clin Pract (1998) 0.76
Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients. Clin Chim Acta (2001) 0.76
The use of sulphonylureas in the elderly. Drugs Aging (1999) 0.76
Consequences of long-term hyperparathyroidism. Neth J Med (1998) 0.76
Effect of miglitol (BAY m-1099) on fasting blood glucose in type 2 diabetes mellitus. Neth J Med (1994) 0.75
Renal graft thrombosis. Transplantation (1995) 0.75
Isolated minimal change nephropathy associated with diclofenac. Br Med J (Clin Res Ed) (1987) 0.75
Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use. Transplantation (1991) 0.75
Aminoguanidine, a potential drug for the treatment of diabetic complications. Neth J Med (1993) 0.75
Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients. Intervirology (1999) 0.75
Ectopic ACTH production by a functioning phaeochromocytoma. Neth J Med (1982) 0.75
[Determination of the urinary albumin excretion in the early case-finding of nephropathy in patients with diabetes mellitus]. Ned Tijdschr Geneeskd (1986) 0.75
Sensitive detection of cytomegalovirus infection in transplant recipients using nucleic acid sequence-based amplification. Transplant Proc (2000) 0.75
Disappearance of pulmonary capillary leak syndrome when intravenous cyclosporine is replaced by oral cyclosporine. Transplantation (1987) 0.75
[Additions to the consensus policy in the diagnosis and treatment of hyperlipidemia in clinical practice]. Ned Tijdschr Geneeskd (1996) 0.75
Low cholesterol and excess mortality: a real relationship? Neth J Med (1993) 0.75
Preservation of renal function and cardiovascular risk factors. Transplant Proc (2006) 0.75
Beta-blockade and carbohydrate metabolism: theoretical aspects and clinical implications. J Cardiovasc Pharmacol (1986) 0.75
Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease? Neth J Med (1998) 0.75
Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers. Br J Clin Pharmacol (1996) 0.75
[Daclizumab and basiliximab: monoclonal mouse-man antibodies with effective immunosuppression without side effects]. Ned Tijdschr Geneeskd (2000) 0.75
The Benelux experience with the combination of tacrolimus and mycophenolate mofetil. Transplant Proc (1999) 0.75
[Treatment of hypercholesterolemia in the elderly]. Ned Tijdschr Geneeskd (1995) 0.75
[Long-term complications in diabetes mellitus: role of irreversible glycosylation products]. Ned Tijdschr Geneeskd (1996) 0.75
Alpha-glucosidase inhibitors in diabetes. Introduction. Eur J Clin Invest (1994) 0.75
Shock of unknown origin--think of mastocytosis! Neth J Med (1997) 0.75
Influence of ACE inhibition on haemoglobin and haematocrit in essential hypertensive patients. Nephrol Dial Transplant (1995) 0.75
The DCCT: "metabolic control matters". Diabetes Control and Complications Trial. Neth J Med (1993) 0.75
Clinical significance of flow cytometry before and after renal transplantation. Transplant Proc (1999) 0.75